Clinical Trials | September 28, 2022
South Korea nextgen sequencing tests market to grow at 4% CAGR during 2022-2030: GlobalData
There is also a growing interest in whole generation sequencing (WGS)
There is also a growing interest in whole generation sequencing (WGS)
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Subscribe To Our Newsletter & Stay Updated
